Literature DB >> 3182751

Hydrolysis of platelet activating factor and its methylated analogs by acetylhydrolases.

R Yanoshita1, I Kudo, K Ikizawa, H W Chang, S Kobayashi, M Ohno, S Nojima, K Inoue.   

Abstract

We examined the substrate specificity of PAF-degrading enzymes from various sources using platelet activating factor (PAF) and its synthetic analogs. The results were as follows: 1) Tissue-originated acetylhydrolases, such as rat kidney soluble enzyme, deacetylated 1S-methyl-1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine (1S-Me-PAF) slightly more rapidly than PAF, whereas plasma acetylhydrolase hydrolyzed PAF more effectively than 1S-Me-PAF. 2) Rat polymorphonuclear leukocytes, monocytes, and lymphocytes homogenates showed an appreciable acetylhydrolase activity, the substrate specificity of which resembled that of the plasma enzyme. 3) Pleural exudates in an experimental pleurisy induced in rats by carrageenan contained an acetylhydrolase activity, the properties of which were similar to those of the plasma enzyme. 4) An extracellular phospholipase A2 activity, which was also observed in the pleural exudate and required Ca2+ ion for maximum activity, seemed not to participate in the deacetylation of PAF, since addition of EDTA did not affect the PAF deacetylation catalyzed by the pleural exudate. These findings indicate that the inactivation reaction of PAF present in the extracellular space is mainly catalyzed by plasma acetylhydrolase, which yields lysoPAF.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3182751     DOI: 10.1093/oxfordjournals.jbchem.a122352

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  7 in total

1.  Determination of phospholipase activity of PAF acetylhydrolase.

Authors:  Diana M Stafforini; Thomas M McIntyre
Journal:  Free Radic Biol Med       Date:  2012-05-29       Impact factor: 7.376

2.  Guinea pig bone marrow cells treated with platelet-activating factor generate factor(s) which affects their DNA synthesis and microbicidal activity.

Authors:  I Kudo; T Kato; H Hayashi; R Yanoshita; K Ikizawa; H Uda; K Inoue
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

3.  Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children.

Authors:  M Miwa; T Miyake; T Yamanaka; J Sugatani; Y Suzuki; S Sakata; Y Araki; M Matsumoto
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 4.  Platelet-activating factor: the biosynthetic and catabolic enzymes.

Authors:  F Snyder
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

5.  Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipase.

Authors:  D M Stafforini; K Satoh; D L Atkinson; L W Tjoelker; C Eberhardt; H Yoshida; T Imaizumi; S Takamatsu; G A Zimmerman; T M McIntyre; P W Gray; S M Prescott
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

6.  Platelet-activating factor acetylhydrolase activity in human tissues and blood cells.

Authors:  D M Stafforini; S M Prescott; G A Zimmerman; T M McIntyre
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

7.  Relationship between platelet activating factor acetylhydrolase activity and apolipoprotein B levels in patients with peanut allergy.

Authors:  Boris Perelman; Areej Adil; Peter Vadas
Journal:  Allergy Asthma Clin Immunol       Date:  2014-04-28       Impact factor: 3.406

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.